OSTEOGENESIS IMPERFECTA

Clinical trials for OSTEOGENESIS IMPERFECTA explained in plain language.

Never miss a new study

Get alerted when new OSTEOGENESIS IMPERFECTA trials appear

Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 2 Not yet finished but already full! 8 Completed 7 Terminated 1

Experimental drug aims to strengthen bones in brittle bone disease

Disease control Terminated

This early-stage study tested a single dose of an experimental drug called SAR439459 in 16 adults with osteogenesis imperfecta (brittle bone disease). The main goal was to check safety and how the drug moves through the body, with a secondary look at bone density changes over 24 …

Matched conditions: OSTEOGENESIS IMPERFECTA

Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

OSTEOGENESIS IMPERFECTA

Get alerted when new OSTEOGENESIS IMPERFECTA trials appear

Experimental drug aims to strengthen bones in brittle bone disease